Turkish Validity and Reliability Study of The Bipolar Recovery Questionnaire

• Sponsor: Bilecik Seyh Edebali Universitesi (Other)
• Overall Status: Active, not recruiting
• CT.gov ID: NCT05679804
• Collaborator: (none)
• Enrollment: 60
• Location: 1
• Anticipated Duration (Months): 5
• Patients Per Site Per Month: 12.1

Study Details

Study Description

Brief Summary

In addition to objective criteria (no episode period for 6 months) for defining and monitoring recovery, evaluation of subjective criteria is also very important. Various Turkish scales related to recovery in progressive diseases have been developed or validity-reliability studies have been conducted. However, as far as we know, there is no scale that evaluates subjective improvement for a disorder such as bipolar disorder that progresses in episodes and has a heterogeneous appearance of loss of functionality. In this study, we aimed to conduct a validity and reliability study of the recovery questionnaire for BDD.

Condition or Disease	Intervention/Treatment	Phase
Bipolar Disorder, Recovery	Other: validity and realibility of scale

Study Design

• Study Type: Observational
• Anticipated Enrollment: 60 participants
• Observational Model: Case-Only
• Time Perspective: Prospective
• Official Title: Turkish Validity and Reliability Study of The Bipolar Recovery Questionnaire
• Actual Study Start Date: Dec 13, 2022
• Anticipated Primary Completion Date: Apr 13, 2023
• Anticipated Study Completion Date: May 13, 2023

Outcome Measures

Primary Outcome Measures

1. validity and reability of scale [5 months]

   turkish validity and reability of Bipolar Recovery Questionnare

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 65 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Being between 18-65 ages

• Be diagnosed with bipolar affective disorder

• Be at least primary school graduate

Exclusion Criteria:

• having a physical disability (blindness, etc.) that might prevent filling in the scales,

• having an additional neurological disease that prevented filling out the scale items.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Bilecik Seyh Edebali University Faculty of Medicine	Bilecik		Turkey	11000

Sponsors and Collaborators

• Bilecik Seyh Edebali Universitesi

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Zehra GÜNAY YAĞCI, Assistant Professor, Bilecik Seyh Edebali Universitesi
• ClinicalTrials.gov Identifier: NCT05679804
• Other Study ID Numbers: BilecikSeyhEU
• First Posted: Jan 11, 2023
• Last Update Posted: Jan 11, 2023
• Last Verified: Dec 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Bipolar Disorder

Study Results

No Results Posted as of Jan 11, 2023